135 related articles for article (PubMed ID: 30836273)
1. Familial multiple sclerosis in a Brazilian sample: Is HLA-DR15 involved in susceptibility to the disease?
da Silva Bernardes M; Antão Paiva CL; Ribeiro Paradela E; Papais Alvarenga M; Ferreira Pereira F; Vasconcelos CC; Papais Alvarenga RM
J Neuroimmunol; 2019 May; 330():74-80. PubMed ID: 30836273
[TBL] [Abstract][Full Text] [Related]
2. Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis.
Rasmussen HB; Kelly MA; Clausen J
Mult Scler; 2001 Apr; 7(2):91-3. PubMed ID: 11424637
[TBL] [Abstract][Full Text] [Related]
3. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
Sayad A
Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928
[TBL] [Abstract][Full Text] [Related]
4. Month of birth is associated with multiple sclerosis but not with HLA-DR15 in Finland.
Saastamoinen KP; Auvinen MK; Tienari PJ
Mult Scler; 2012 May; 18(5):563-8. PubMed ID: 22041092
[TBL] [Abstract][Full Text] [Related]
5. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients.
Amirzargar A; Mytilineos J; Yousefipour A; Farjadian S; Scherer S; Opelz G; Ghaderi A
Eur J Immunogenet; 1998 Aug; 25(4):297-301. PubMed ID: 9777330
[TBL] [Abstract][Full Text] [Related]
6. Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis.
Simon KC; Munger KL; Kraft P; Hunter DJ; De Jager PL; Ascherio A
J Neurol; 2011 Sep; 258(9):1676-82. PubMed ID: 21431378
[TBL] [Abstract][Full Text] [Related]
7. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C
Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466
[TBL] [Abstract][Full Text] [Related]
8. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
[TBL] [Abstract][Full Text] [Related]
9. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR15 haplotype and multiple sclerosis: a HuGE review.
Schmidt H; Williamson D; Ashley-Koch A
Am J Epidemiol; 2007 May; 165(10):1097-109. PubMed ID: 17329717
[TBL] [Abstract][Full Text] [Related]
11. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
[TBL] [Abstract][Full Text] [Related]
12. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
[TBL] [Abstract][Full Text] [Related]
13. Association of
Xue K; Niu WQ; Cui Y
Chin Med J (Engl); 2018 Dec; 131(23):2844-2851. PubMed ID: 30511687
[TBL] [Abstract][Full Text] [Related]
14. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
[TBL] [Abstract][Full Text] [Related]
15. HLA associations with multiple sclerosis in Greece.
Kouri I; Papakonstantinou S; Bempes V; Vasiliadis HS; Kyritsis AP; Pelidou SH
J Neurol Sci; 2011 Sep; 308(1-2):28-31. PubMed ID: 21741664
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.
Simon KC; Schmidt H; Loud S; Ascherio A
Mult Scler; 2015 May; 21(6):703-9. PubMed ID: 25305254
[TBL] [Abstract][Full Text] [Related]
17. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
18. Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15.
Enz LS; Zeis T; Schmid D; Geier F; van der Meer F; Steiner G; Certa U; Binder TMC; Stadelmann C; Martin R; Schaeren-Wiemers N
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31882398
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.
Mohme M; Hotz C; Stevanovic S; Binder T; Lee JH; Okoniewski M; Eiermann T; Sospedra M; Rammensee HG; Martin R
Brain; 2013 Jun; 136(Pt 6):1783-98. PubMed ID: 23739916
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
Masterman T; Ligers A; Olsson T; Andersson M; Olerup O; Hillert J
Ann Neurol; 2000 Aug; 48(2):211-9. PubMed ID: 10939572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]